PSD is honored to contribute to advancing Thai immunotherapy in partnership with the Siriraj Foundation.

On April 22, PSD Construction 2011 Co., Ltd. and PSD Group proudly supported the Siriraj Immunotherapy Development Fund, a foundation dedicated to advancing research and development in cancer treatment through cellular immunotherapy. This innovative approach involves extracting a patient’s immune cells, modifying and stimulating them in the laboratory to enhance their ability to target and destroy cancer cells, expanding their number, and then reintroducing them into the patient’s body. These immune cells are considered a “living drug” due to their safety and high efficacy in cancer treatment. Executives from PSD Group presented a donation of 200,000 THB to the Siriraj Foundation at the Hematology Laboratory, Department of Medicine, 12th Floor, Chalermprakiat Building, Siriraj Hospital.

This initiative is part of the company’s Corporate Social Responsibility (CSR) policy, which emphasizes promoting public health through the support of medical and public health initiatives. PSD Group is committed to contributing to the sustainable advancement of medical knowledge and innovation, which will lead to more effective treatments and help countless patients regain a better quality of life.